Health 3 min read

NHS Records Busiest Ever A&E Month with 2.43 Million Attendances in March 2026

NHS England has recorded its busiest ever A&E month in March 2026 with 2.43 million attendances, while the elective care waiting list stands at 7.25 million patients. Over 38% of A&E patients waited longer than the four-hour target despite the record demand. The NHS is advancing new treatments including an RSV vaccine and Wegovy for cardiovascular patients, but health leaders warn that targets will be extremely difficult to meet without further investment.

Titanic NewsSaturday, 18 April 20266 views
NHS Records Busiest Ever A&E Month with 2.43 Million Attendances in March 2026

NHS Records Busiest Ever A&E Month with 2.43 Million Attendances in March 2026

NHS England has described March 2026 as its busiest month ever for accident and emergency services, with a record 2.43 million attendances, as the health service continues to grapple with an elective care waiting list of 7.25 million patients.

Background

The National Health Service has been operating under extreme pressure for several years, with demand for services consistently outpacing capacity. The elective care waiting list, which peaked at 7.7 million, has seen only modest reductions despite significant government investment and reform efforts. Urgent and emergency care services have been particularly stretched, with A&E departments across England regularly failing to meet the four-hour waiting time target.

Key Developments

NHS England confirmed that March 2026 was its busiest ever month for A&E, with a record 2.43 million attendances. Despite this unprecedented demand, over 38% of patients still waited longer than the four-hour target. Average ambulance response times for serious conditions such as strokes and heart attacks, while meeting the relaxed 2026/27 target, remained well above the constitutional standard of 18 minutes.

The elective care waiting list currently stands at 7.25 million, according to a comprehensive report from Wecovr. Although this represents a slight reduction from the peak of 7.7 million, the national target of treating 92% of patients within 18 weeks has not been achieved since 2016. The NHS is also advancing new treatments, with millions of older individuals now eligible for a newly available RSV vaccine, and semaglutide (Wegovy) expected to be available for 1.2 million people with cardiovascular disease within months.

Why It Matters

The record A&E figures are a stark indicator of the scale of demand facing the NHS and the gap between current performance and the standards patients are entitled to expect. For the millions of people who attended A&E in March, the experience of long waits in overcrowded departments has real consequences for health outcomes, particularly for those with time-sensitive conditions.

The persistence of the 7.25 million waiting list also means that millions of people are living with untreated conditions, often in pain and unable to work, with significant knock-on effects for the wider economy and social fabric.

What's Next

The government has set ambitious targets for reducing waiting times and improving A&E performance in 2026/27. The rollout of the NHS App and the AI-enabled Federated Data Platform are expected to improve efficiency, but many health leaders warn that without significant additional investment and workforce expansion, the targets will be extremely difficult to meet. Further details are available at NHS England.

What's Your Take?

NHSA&Ewaiting listNHS Englandhealth crisis

Related Stories

NHS Bowel Cancer Screening Programme Has Detected 70,000 Cancers Since Launch, NHS England Reports
Health

NHS Bowel Cancer Screening Programme Has Detected 70,000 Cancers Since Launch, NHS England Reports

NHS England has announced that its bowel cancer screening programme has detected 70,000 cancers since its launch, with nearly 7 million people screened in 2024/25 β€” up from 4.7 million a decade ago. The milestone comes as the NHS also launches its spring COVID-19 vaccination programme for over-75s and immunosuppressed individuals. The GLP-1 drug semaglutide is also set to become available on the NHS to prevent heart attacks and strokes for 1.2 million people.

Titanic News
3 min read21 Apr 2026
NHS Launches Spring COVID-19 Vaccination Programme for Over-75s and Vulnerable Groups
Health

NHS Launches Spring COVID-19 Vaccination Programme for Over-75s and Vulnerable Groups

The NHS has launched its 2026 spring COVID-19 vaccination programme, offering protection to individuals aged 75 and over, older care home residents, and immunosuppressed individuals. Tens of thousands of appointments are available daily at GP practices and community pharmacies across England. The programme runs alongside a new RSV vaccination initiative for older adults aimed at preventing thousands of annual hospital admissions.

Titanic News
3 min read21 Apr 2026
NHS Launches Spring COVID-19 and RSV Vaccination Drives for Millions of Vulnerable People
Health

NHS Launches Spring COVID-19 and RSV Vaccination Drives for Millions of Vulnerable People

The NHS has launched its spring vaccination campaigns, offering COVID-19 boosters to those aged 75 and over, care home residents, and immunocompromised individuals, while rolling out a new RSV vaccine for adults aged 80 and over. The dual drive targets the most vulnerable groups ahead of the next respiratory virus season.

Titanic News
2 min read20 Apr 2026
Legionnaires' Disease Outbreak Under Investigation in London as Cases Rise
Health

Legionnaires' Disease Outbreak Under Investigation in London as Cases Rise

The UK Health Security Agency is investigating an unusual Legionnaires' Disease outbreak in London, with eight confirmed cases sharing an identical genetic sequence in North West and South West London and 13 further cases under investigation. No common source has been identified, and authorities are implementing urgent control measures including cooling tower inspections and shock-dosing.

Titanic News
2 min read20 Apr 2026